Alterity Therapeutics Ltd ATHE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/08/24 EDT
2.15quote price arrow up+0.11 (+5.39%)
Volume
471
Close
2.04UNCH (UNCH)
Volume
16,004
52 week range
1.55 - 5.41
Loading...
  • Open2.10
  • Day High2.23
  • Day Low2.04
  • Prev Close2.04
  • 52 Week High5.41
  • 52 Week High Date12/04/23
  • 52 Week Low1.55
  • 52 Week Low Date02/23/24

Key Stats

  • Market Cap17.833M
  • Shares Out8.74M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta0.86
  • YTD % Change-18.07

KEY STATS

  • Open2.10
  • Day High2.23
  • Day Low2.04
  • Prev Close2.04
  • 52 Week High5.41
  • 52 Week High Date12/04/23
  • 52 Week Low1.55
  • 52 Week Low Date02/23/24
  • Market Cap17.833M
  • Shares Out8.74M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta0.86
  • YTD % Change-18.07

RATIOS/PROFITABILITY

  • EPS (TTM)-2.03
  • P/E (TTM)-1.01
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-9.333M
  • ROE (TTM)-53.72%
  • Revenue (TTM)81,430.003
  • Gross Margin (TTM)-
  • Net Margin (TTM)-9,947.97%
  • Debt To Equity (MRQ)1.45%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Alterity Therapeutics Ltd

 

Profile

MORE
Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company’s lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson’s disease, as well as various Parkinsonian disorders...
Geoffrey Kempler
Non-Executive Chairman of the Board
David Stamler M.D.
Chief Executive Officer
Phillip Hains
Chief Financial Officer, Company Secretary
Address
L 3 460 Bourke St
Melbourne, VIC
3000
Australia

Top Peers

SYMBOLLASTCHG%CHG
AKTX
Akari Therapeutics PLC
1.42UNCHUNCH
ONVO
Organovo Holdings Inc
0.96UNCHUNCH
IKT
Inhibikase Therapeutics Inc
1.40UNCHUNCH
HEPA
Hepion Pharmaceuticals Inc
1.31UNCHUNCH
VIRI
Virios Therapeutics Inc
0.429UNCHUNCH